BioCatalystWatch
FBRXWorkspace / FBRX / OverviewCompany library
FORTE BIOSCIENCES, INC. logo

FORTE BIOSCIENCES, INC.

FORTE BIOSCIENCES, INC. (FBRX)

Website

Price
Market cap
Next catalystExpected 2H 2026FB102 · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

FB102

CD122 (IL-2/IL-15 receptor β subunit)

PreINDP1P2P3FilingApproved
Upcoming / outlook

FB102

CD122 (IL-2/IL-15 receptor β subunit)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

FB102

CD122 (IL-2/IL-15 receptor β subunit)

PreINDP1P2P3FilingApproved
Upcoming / outlook

FB102

CD122 (IL-2/IL-15 receptor β subunit)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

FB102

CD122 (IL-2/IL-15 receptor β subunit)

PreINDP1P2P3FilingApproved
FB102

CD122 (IL-2/IL-15 receptor β subunit)

FB102

CD122 (IL-2/IL-15 receptor β subunit)

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing


PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing


PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

FBRX PR & News

PR & News

FBRX SEC archive